Product & ReviewsAntibodies

anti-AAV8 (intact particle) mouse monoclonal, ADK8, lyophilized, purified

For characterization of different stages of infection and very useful for the analysis of the AAV assembly process. ADK8 specifically reacts with AAV1, AAV3, AAV7, AAV8, AAVrh10, AAVrh74 and Anc80, empty and full capsids. Recognizes a conformational epitope of assembled capsids. Predicted binding site: residues 586-LQQQNT-591 (Gurda et al. 2012). The antibody cannot be used for immunoblotting using denaturing conditions. The antibody is also useful for neutralizing experiments. Gurda, B. L

Product Details

Cat. No.
610160
Type
Primary Antibody
Clonality
Monoclonal
Host
Mouse
PROGEN

The supplier does not provide quotations for this antibody through SelectScience. You can search for similar antibodies in our  Antibody Directory.

Reviews

Average Rating 5.0

|1Scientists have reviewed this product

Specificity rating
Sensitivity rating
Quality rating
Write your own review

Great stability.

 

Average Rating 5.0

Application Area:

Flow cytometry

We have been buying from Progen for many years. This is due to the effectiveness of their products. Following protocol produces the outcomes we desire with no variance between lots. Greatly recommend this company.

Review Date: 12 Feb 2020 | PROGEN

Applications

  • Dot Blot (DB)
  • ELISA (ELISA)
  • Immunocytochemistry (ICC)
  • Immunohistochemistry (IHC)
  • Immunoprecipitation (IP)
  • Neutralization (Neut)

Antibody Overview

About the company

PROGEN logo

PROGEN

Since 1983, PROGEN has been an established manufacturer and supplier of premium antibodies, in vitro diagnostics, and reagents for the global life science research community. The company’s portfolio attracts and serves a well-diversified clientele in research institutes and universities, pharmaceutical and biotech companies as well as private and clinical laboratories. While PROGEN ’s antibodies are among the most published antibodies in biomedical and cell biology literature, its ELISA kits aim at niche markets in microbiology, infectious diseases, and immunology. Building on its extensive core-competency and experience in immunochemistry, the company has expanded its product and service portfolio in recent years to include recombinant antibody engineering, antibody phage display technology, density gradient media, and AAV (adeno-associated virus) test kits for gene therapy research.

4.9/5.0
|15 Reviews